- Home
- FTRE vs PDX Comparison
FTRE vs PDX Comparison
Compare FTRE & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- PDX
- Stock Information
- Founded
- FTRE 1996
- PDX 2019
- Country
- FTRE United States
- PDX NY
- Employees
- FTRE N/A
- PDX N/A
- Industry
- FTRE Medical Specialities
- PDX Finance/Investors Services
- Sector
- FTRE Health Care
- PDX Finance
- Exchange
- FTRE Nasdaq
- PDX Nasdaq
- Market Cap
- FTRE 469.0M
- PDX 1.1B
- IPO Year
- FTRE N/A
- PDX N/A
- Fundamental
- Price
- FTRE $5.95
- PDX $22.15
- Analyst Decision
- FTRE Hold
- PDX
- Analyst Count
- FTRE 11
- PDX 0
- Target Price
- FTRE $18.00
- PDX N/A
- AVG Volume (30 Days)
- FTRE 2.3M
- PDX N/A
- Earning Date
- FTRE 05-12-2025
- PDX 01-01-0001
- Dividend Yield
- FTRE N/A
- PDX 4.95%
- EPS Growth
- FTRE N/A
- PDX N/A
- EPS
- FTRE N/A
- PDX N/A
- Revenue
- FTRE $2,696,400,000.00
- PDX N/A
- Revenue This Year
- FTRE N/A
- PDX N/A
- Revenue Next Year
- FTRE $3.32
- PDX N/A
- P/E Ratio
- FTRE N/A
- PDX N/A
- Revenue Growth
- FTRE N/A
- PDX N/A
- 52 Week Low
- FTRE $4.77
- PDX $13.52
- 52 Week High
- FTRE $37.24
- PDX $21.05
- Technical
- Relative Strength Index (RSI)
- FTRE 43.28
- PDX 50.77
- Support Level
- FTRE $5.40
- PDX $21.85
- Resistance Level
- FTRE $6.38
- PDX $22.85
- Average True Range (ATR)
- FTRE 0.45
- PDX 0.54
- MACD
- FTRE 0.21
- PDX 0.21
- Stochastic Oscillator
- FTRE 72.52
- PDX 67.74
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.